Lundbeck Inc.'s Ambition: Hopes To Launch New Alzheimer's Drug In 2017

Danish pharmaceutical group Lundbeck said on Monday that it hopes to launch a new Alzheimer's medicine in 2017 in what would be the first new drug for the condition in more than a decade. Dementia - of which Alzheimer's disease is the most common form - already affects 44 million people worldwide and is set to reach 135 million by 2050, according to non-profit campaign group Alzheimer's Disease International.

Help employers find you! Check out all the jobs and post your resume.